Rebound after cessation of oral anticoagulant therapy: The biochemical evidence

British Journal of Haematology

Volumn 92, Issue 2, 1996, Pages 479-485

  Genewein, Urs ^a   Haeberli, André ^a   Straub, P Werner ^a   Beer, Jürg H ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b Kinderklinik   (Switzerland)

Author keywords

Oral anticoagulant therapy; Procoagulant markers; Rebound effect; Thrombin antithrombin III complexes; Thromboembolism

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ANTITHROMBIN III; FIBRIN; PHENPROCOUMON; THROMBIN;

ADULT; ARTICLE; BLEEDING DISORDER; CLINICAL ARTICLE; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERCOAGULABILITY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTHROMBIN TIME; REBOUND; THROMBOEMBOLISM;

EID: 0030032111     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1499.x     Document Type: Article

References (49)

1. Bauer, K.A. & Rosenberg, R.D. (1989) Congenital antithrombin III deficiency: insight into the pathogenesis of the hypercoagulable state and its management using markers of hemostatic system activation. American Journal of Medicine, 187, (Suppl. 3B). 39S-43S.
2. Bauer, K.A., Weiss, L.M., Sparrow, D., Vokonas, P.S. & Rosenberg, R.D. (1987) Aging-associated changes in indices of thrombin generation and protein C activation in humans: normative aging study. Journal of Clinical Investigation, 80, 1527-1534.
3. Beer, J.H. & Schlup, P. (1986) Myokardinfarktrezidiv nach Absetzen der oralen Antikoagulation: fataler Rebound für bestimmte Risikogruppen? Schweizerische Medizinische Wochenschrift, 116, 429-431.
4. Bremme, K., Ostlund, E., Almqvist, I., Heinonen, K. & Blomback, M. (1992) Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstetrics and Gynecology, 80, 132-137.
5. Carter, S.A., McDevitt, E., Gatje, B.W. & Wright, I.S. (1958) Analysis of factors affecting the recurrence of thromboembolism off and on anticoagulation therapy. American Journal of Medicine, 25, 43-51.
6. Conway, E.M., Bauer, K.A., Barzegar, S. & Rosenberg, R.D. (1987) Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses. Journal of Clinical Investigation, 80, 1535-1544.
7. Côté, P., Lamontagne, R., Campeau, L. & Bourassa, M.G. (1977) Risks of discontinuing anticoagulant therapy in a selected group of patients with atherosclerotic heart disease: a prospective study. Canadian Medical Association Journal, 117, 1281-1284.
8. De Buyzere, M., Phillippé, J., Duprez, D., Baele, G. & Clement, D.L. (1993) Coagulation system activation and increase of D-dimer levels in peripheral arterial occlusive disease. American Journal of Hematology, 43, 91-94.
9. De Vries, W.A., Thijssen, J.G.P., Loeliger, E.A. & Roos, J. (1980) A double blind trial to assess long-term anticoagulant therapy in elderly patients after myocardial infarction: report of the sixty-plus reinfarction study research group. Lancet, ii, 989-994.
10. Dinon, L.R. & Vander Veer, J.B. (1969) Recurrent myocardial infarction after cessation of anticoagulant therapy. American Heart Journal, 60, 6-22.
11. Evans, R.W. & O'Rourke, R.A. (1970) Thromboembolic complications after anticoagulant withdrawal. Military Medicine, 135, 1157-1160.
12. Ferland, G., Sadowski, J.A. & O'Brien, M.E. (1993) Dietary induced subclinical vitamin K deficiency in normal human subjects. Journal of Clinical Investigation, 91, 1761-1768.
13. Gold, H.K., Torres, F.W., Garabedian, H.D., Werner, W., Jang, I.K., Kran, A., Hagstrom, J.N., Yasuda, T., Leinbacb, R.C., Newell, J.B., Bovill, E.G., Stump, D.C. & Coller, D. (1993) Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris. Journal of the American College of Cardiology, 21, 1039-1047.
14. Grip, L., Blombäck, M. & Schulman, S. (1991) Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients. European Heart Journal, 12, 1225-1233.
15. Harenberg, J., Haas, R. & Zimmermann, R. (1983) Plasma hypercoagulabilily after termination of oral anticoagulants. Thrombosis Research, 29, 627-633.
16. Hart, R.G. & Coull, B.N. (1983) Hypercoagulability following coumarin withdrawal. American Heart Journal, 106, 169-170.
17. Herren, T., Bärtsch, P., Haeberli, A. & Straub, P.W. (1992) Increased thrombin-antithrombin III complexes after 1h of physical exercise. Journal of Applied Physiology. 73, 2499-2504.
18. Herren, T., Stricker, H.P., Haeberli, A., Do, D.D. & Straub, P.W. (1994) Fibrin formation and degradation in patients with arteriosclerotic disease. Circulation, 90, 2679-2686.
19. Hursting, M.J., Stead, A.G., Crout, F.V., Horvath, B.Z. & Moore, B.M. (1993) Effects of age, race, sex, and smoking on prothrombin fragment 1.2 in a healthy population. Clinical Chemistry, 39, 682-686.
20. 1 and warfarin on prothrombin expression in human hepatoblastoma (HepG2) cells. Thrombosis and Haemostasis, 68, 40-47.
21. Kamath, V.R. & Thorne, M.G. (1969) Ischaemic heart-disease and withdrawal of anticoagulant therapy. Lancet, 24, 1025-1027.
22. Karpatkin, S., Finlay, T.H., Ballesteros, A.L. & Karpatkin, M. (1987) Effect of warfarin on prothrombin synthesis and secretion in human HEP G2 cells. Blood, 70, 773-778.
23. Keyes, J.W., Drake, E.H. & Smith, F.J. (1956) Survival rates after acute myocardial infarction with long-term anticoagulant therapy. Circulation, 14, 254-259.
24. Kuhn, P.R., Van Ness, A.L., Jones, R.J. & Bay, E.B. (1961) Long-term anticoagulant therapy after acute myocardial infarction. Archives of Internal Medicine, 108, 884-896.
25. Liebermann, J.S. & Lindner, M. (1965) Elective termination of anticoagulation in coronary artery disease. Circulation, 138, (Suppl. II), 31-32.
26. Mannucci, P.M., Tripodi, A., Bottasso, B., Boudo, F., Finazzi, G., De Stefano, V., Palareti, G., Manotti, C. Mazzunconi, G. & Castaman, G. (1992) Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes. Thrombosis and Haemostasis, 67, 200-202.
27. Marshall, J. (1963) Rebound phenomena after anticoagulant therapy in cerebrovascular disease. Circulation, 25, 329.
28. McGinty, D.A., Seegers, W.A., Pfeiffer, C.C. & Loew, E.R. (1942) Plasma prothrombin concentration in dogs given 3.3′-methylene-bis(4-hydroxycoumarin) and purified beef prothrombin. Science, 96, 540.
29. Michaels, L. & Beamish, R.E. (1967) Relapses of thromboembolic disease after discontinued anticoagulant therapy: a comparison of the incidence after abrupt and after gradual termination of treatment. American Journal of Cardiology, 20, 670-673.
30. Michaels, L. (1970) Recurrence of thromboembolic disease after discontinuing anticoagulant therapy; a study of factors affecting incidence. British Heart Journal, 32, 359-364.
31. Millenson, M.M., Bauer, K.A., Kistler, J.P., Barzegar, S., Tulin, L. & Rosenberg, R.D. (1992) Monitoring 'mini-intensity' anticoagulation with warfarin: comparison of the prothrombin time using a sensitive thromboplastin with prothrombin fragment F1 + 2 levels. Blood, 79, 2034-2038.
32. Miller, K.D. & Bayer, W.L (1961) Prothrombin rebound: a response to dicoumarol. Blood, 17, 365.
33. Nichol, H.S., Keyes, J.N., Borg, J.F., Coogan, T.J., Boehrer, J.J., Mullins, W.L., Scott, T., Page, R., Griffith, G.C. & Massu, E. 1958) Long-term anticoagulant therapy in coronary atherosclerosis. American Heart Journal, 55, 142-152.
34. Palareti, G., Legnani, C., Guazzaloca, G., Frascaro, M., Grauso, F., De Rosa, F., Fortunato, G. & Coccheri, S. (1994) Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants, a prospective study. Thrombosis and Haemostasis, 72, 222-226.
35. Pickering, G., Arnottt, W.M., Biggs, R., Fullerton, H.W., Gilchrist, A.R., Hunter, R.B., Reid, D.D., Wood, P., Wright, J.H. & Douglas, A.S. (1964) An assessment of long-term anticoagulant administration after cardiac infarction. British Medical Journal, ii, 837-843.
36. Poller, L. & Thomson, J. (1964) Evidence for 'rebound' hypercoagulability after stopping anticoagulants. Lancet, ii, 62-64.
37. Poller, L. & Thomson, J.M. (1965) Reduction of 'rebound' hypercoagulability by gradual withdrawal ('tailing off) of oral anticoagulants. British Medical Journal, i, 1475-1476.
38. Rosenberg, R.D. & Bauer, K.A. (1992) Does a prethrombotic state exist? If so, what is it? American Journal of Clinical Nutrition, 56, 787S-788S.
39. Sharland, D.H. (1966) Effect of cessation of anticoagulant therapy on the course of ischaemic heart disease. British Medical Journal, ii, 392-393.
40. Sise, H.S., Moschos, C.B., Gauthier, J. & Becker, R. (1961) The risk of interrupting long-term anticoagulant treatment. Circulation, 24, 1137-1142.
41. Suttie, J.W. (1993) Synthesis of vitamin K-dependenl proteins. FASEB Journal; Federation of American Societies for Experimental Biology, 7, 445-452.
42. The DVTENOX Study Group (1995) Markers of hemostatic system activation in acute deep venous thrombosis-evolution during the first days of heparin treatment. Thrombosis and Haemostasis, 70, 909-914.
43. Théroux, P., Waters, D., Lam, J., Juneau, M. & McCans, J. (1992) Reactivation of unstable angina after the discontinuation of heparin. New England Journal of Medicine, 327, 141-145.
44. Thomes, B., Scallen, R.W. & Savage, R. (1960) The prophylactic value of long-term anticoagulant therapy. Circulation, 21, 354-362.
45. Van Cleve, R. (1965) The rebound phenomenon - fact or fancy? Experience with discontinuation of long-term anticoagulation therapy after myocardial infarction. Circulation, 32, 878-880.
46. Van Cleve, R. (1966) Letting go of the bear's tail: experience with discontinuation of long-term anticoagulant therapy. Journal of the American Medical Association, 196, 1156-1158.
47. Willerson, J.T. & Casscells, W. (1963) Thrombin inhibitors in unstable angina: rebound or continuation of angina after argatroban withdrawal? Journal of the American College of Cardiology, 21, 1048-1051.
48. Wright, I.S. (1960) Treatment of thromboembolic diseases. Journal of the American Medical Association, 174, 1921-1924.
49. Wright, I.S. (1961) A bear by the tail? The discontinuance of anticoagulant therapy. Diseases of Chest, 40, 454-456.